Lipoprotein(a), left atrial appendage function and thromboembolic risk in patients with chronic nonvalvular atrial fibrillation

Japanese Circulation Journal

Volumn 64, Issue 2, 2000, Pages 93-98

  Igarashi, Yutaka ^a   Kasai, Hidehiro ^b   Yamashita, Fumio ^b   Sato, Tadashi ^a   Inuzuka, Hiroshi ^a   Ojima, Kenji ^a   Aizawa, Yoshifusa ^b  

^a Tsuruoka City Shonai Hospital   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Atrial fibrillation; Left atrial appendage; Lipoprotein(a); Thromboembolism; Transesophageal echocardiography

Indexed keywords

FIBRINOGEN; LIPOPROTEIN A;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART ATRIUM FUNCTION; HEART ATRIUM THROMBOSIS; HEART LEFT ATRIUM; HEART VOLUME; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREDICTION; RISK ASSESSMENT; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; ATRIAL FIBRILLATION; ATRIAL FUNCTION, LEFT; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; RISK; THROMBOEMBOLISM;

EID: 0034051841     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.64.93     Document Type: Article

References (37)

1. Valeline RJ, Grayburn A, Vega GL, Gundy SM: Lp(a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white men. Arch Intern Med 1994; 154: 801-806
2. Nguyen TT, Ellefson RD, Hodge DO, Bailey KR, Kottke TE, AbuLebdeh HS: Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women. Circulation 1997; 96: 1390-1397
3. Saku K, Zhang B, Liu R, Shirai K, Arakawa K: Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a). Jpn Circ J 1999; 63: 659-665
4. Loscalzo J, Weinfeld M, Fless GM, Scanu AM: Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis 1990; 10: 240-245
5. Dahlen GH: Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 1994; 108: 111-126
6. Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF: A potential basis for the thrombotic risks associated with lipoprotein(a). Nature 1989; 339: 301-303
7. McLean JW, Tomlison JE, Kuang W, Eaton DL, Chen EY, Fless GM, et al: cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987; 300: 132-137
8. Hajjar KA, Gavish D, Breslow JL, Nachman RL: Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989; 339: 303-305
9. Moliterno DJ, Lange RA, Meidell RS, Willard JE, Leffert CC, Gerard RD, et al: Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction. Circulation 1993; 88: 935-940
10. Biemond BJ, Friederich PW, Koschinsky ML, Levi M, Sangrar WS, Xia J, et al: Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo. Circulation 1997; 96: 1612-1615
11. Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB: Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham study. Neurology 1978; 28: 973-977
12. Cairns JA, Connolly SJ: Nonrheumatic atrial fibrillation: Risk of stroke and role of antithrombotic therapy. Circulation 1991; 84: 469-481
13. Aschenberg W, Schluter M, Kremer P, Schroder E, Siglow V, Bleifeld W: Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombus. J Am Coll Cardiol 1986; 7: 163-166
14. Stoddard MF, Dawkins PR, Prince CR, Ammash NM: Left atrial appengade thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolie event: a transesophageal echocardiographic study. J Am Coll Cardiol 1995; 25: 452-459
15. Pollick C, Taylor D: Assessment of left atrial appendage function by transesophageal echocardiography: Implications for the development of thrombus. Circulation 1991; 84: 223-231
16. Chimowit MI, DeGeorgia MA, Poole RM, Hepner A, Armstrong WM: Left atrial spontaneous echo contrast is highly associated with previous stroke in patients with atrial fibrillation or mitral stenosis. Stroke 1993; 24: 1015-1019
17. Mugge A, Kuhn H, Nikutta P, Grote J, Lopez AG, Daniel: Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: Identification of a subgroup of patients at increased embolie risk. J Am Coll Cardiol 1994; 23: 599-607
18. Leung DYC, Black IW, Cranney GB, Hopkins AP, Walsh WF: Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. J Am Coll Cardiol 1994; 24: 755-762
19. Igarashi Y, Yamaura M, Ito M, Inuzuka H, Ojima K, Aizawa Y: Elevated serum lipoprotein(a) is a risk factor for left atrial thrombus in patients with chronic atrial fibrillation: A transesophageal echocardiographic study. Am Heart J 1998; 136: 965-971
20. Collins LJ, Silverman DI, Douglas PS, Manning WJ: Cardioversion of nonrheumatic atrial fibrillation: reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. Circulation 1995; 92: 156-159
21. Sahn DJ, MeMaria A, Kisslo J, Weyman A: Recommendations recording quantitation of M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083
22. Beppu S, Nimura Y, Sakakibara H, Nagata S, Park YD, Izumi S, et al: Smoke-like echo in the left atrial cavity in mitral valve disease: Its features and significance. J Am Coll Cardiol 1985; 6: 744-749
23. Oshima S, Uchida K, Yasu T, Uno K, Nonogi H, Haze K: Transient increase of plasma lipoprotein(a) in patients with unstable angina pectoris: does lipoprotein(a) alter fibrinolysis? Arterioscler Thromb 1991; 11: 1772-1777
24. Rader DJ, Brewer HB: Lipoprotein(a): clinical approach to a unique atherogenic lipoprotein. JAMA 1992; 267: 1109-1112
25. Fatkin D, Kelly RP, Feneley MP: Relations between left atrial appendage blood flow velocity, spontaneous echo contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994; 23: 961-969
26. Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, Hart RG: Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. J Am Coll Cardiol 1998; 31: 1622-1626
27. Stroke prevention in atrial fibrillation investigators: Stroke prevention in atrial fibrillation study: final results. Circulation 1991; 84: 527-539
28. European atrial fibrillation trial study group: Optimal oral anticoagulation therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 1995; 333: 5-10
29. Stroke prevention in atrial fibrillation investigators: Predictors of thromboembolism in atrial fibrillation. I. Clinical features of patients at risk. Ann Intern Med 1992; 116: 1-5
30. Hylek E, Skates SJ, Sheehan MA, Singer DE: An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996; 335: 540-546
31. Stroke prevention in atrial fibrillation investigators: Warfarin vs. aspirin for prevention of thromboembolism in atrial fibrillation: Stroke prevention in atrial fibrillation II study. Lancet 1994; 343: 687-691
32. Atrial fibrillation investigators: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 1994; 154: 1449-1457
33. Stroke prevention in atrial fibrillation investigators: Predictors of thromboembolism in atrial fibrillation. II, Echocardiographic features of patients at risk. Ann Intern Med 1992; 116: 6-12
34. Leung DY, Davidson PM, Cranney GB, Walsh WF: Thromboembolic risks of left atrial thrombus detected by transesophageal echocardiogram. Am J Cardiol 1997; 79: 626-629
35. Fatkin D, Herbert E, Fenely MP: Hematologic correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk. Am J Cardiol 1994; 73: 672-676
36. Black IW, Chesterman CN, Hopkins AP, Lee LCL, Chong BH, Walsh WF: Hematologic correlates of left spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation. J Am Coll Cardiol 1993; 21: 451-457
37. Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawabe M: Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis 1989; 78: 145-150